Sarofim Fayez’s Biogen BIIB Stock Holding History

Sarofim Fayez’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$1.11M	Buy	+4,600	New	+$1.03M	0.01%	138

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sarofim Fayez's BIIB Position: Q3 2013 in Review

Sarofim Fayez opened a new position in Biogen (BIIB) in Q3 2013: 4,600 shares worth $1.11M. The stake represents 0.01% of the portfolio and ranks #138 among its holdings.

656 funds tracked by Wall St. Rank hold BIIB as of Q3 2013.

Sarofim Fayez held 4,600 shares of Biogen worth $1.11M as of Q3 2013.
Biogen was a new Sarofim Fayez position in Q3 2013.
Biogen made up 0.01% of Sarofim Fayez's portfolio in Q3 2013, its #138 holding.
656 funds tracked by Wall St. Rank held Biogen as of Q3 2013.

Based on Sarofim Fayez's 13F filing for Q3 2013, filed 14 Nov 2013.